Header Logo

Connection

NAVEEN PEMMARAJU to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications NAVEEN PEMMARAJU has written about Clinical Trials, Phase I as Topic.
NAVEEN PEMMARAJU
Connection Strength
0.167
Clinical Trials, Phase I as Topic
  1. Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Expert Opin Pharmacother. 2022 Mar; 23(4):431-438.
    View in: PubMed
    Score: 0.167
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.